Menu Back toSession 4 : Korea’s Strategy for going Global

NiFDS-DIA Workshop 2021: Facilitating the Development and Regulations of Covid-19 Vaccines and Treatments / Current Trends in New Drug Development and Regulations

The timing is as per Korean Time Zone

Session 4 : Korea’s Strategy for going Global

Session Chair(s)

Junesik  Mune, MD, PhD

Junesik Mune, MD, PhD

  • VP, Clinical & Regulatory Affairs Center
  • LG Chem, Korea, Republic of


Meejeong  Lee

Meejeong Lee

  • SK biopharmaceuticals, Korea, Republic of
Kyung Ae  Yoon

Kyung Ae Yoon

  • Patent Attorney
  • YULCHON LLC, Korea, Republic of
Sun Young  Yum

Sun Young Yum

  • Vice President, Clinical Development Strategy
  • Bridge Biotherapeutics Inc., Korea, Republic of

Contact us

Please contact DIA Japan for further information.

Send Email